IL6 and renal carcinoma: Mizutani et al. [36] showed that blocking IL-6 increased chemosensitivity to cisplatin in renal cancer cells, and our recently published results also showed that IL-6 plays a role in chemoresistance in NSCLC cells by increasing DNA repair and blocking apoptosis [37].